Our technology and capabilities can enhance existing products or create
entirely new products in a broad range of areas including:
· Gene Therapy
· Gene Modulation
(e.g., RNAi and microRNA)
· Protein Therapeutics
· Genetic vaccines
· Protein screening/Disease models
Great science can’t happen alone.
Here at REGENX, we believe that the future of gene therapy and particularly the use of recombinant adeno-associated viral vectors can never rest in the hands of a single company or institution. We are dedicated to developing and working with a global network of leading researchers and physicians from the private and public sectors who can work together to realize the promise of these exciting new technologies. To learn more about the science behind REGENX, please visit:
Research: Current research on AAV and NAV technologies and therapeutic applications.
Connect with REGENX
Learn more about our NAV™ Technology. We are actively focused on building collaboration opportunities.